Skip to main content
Download PDF

Evaluation of semen DNA integrity and related parameters with COVID-19 infection: a prospective cohort study

Virology Journal volume 20, Article number: 218 (2023) Cite this article

Abstract

Background

In the context of Corona Virus Disease 2019 (COVID-19) global pandemic, Its impact on male reproductive function should be concerned.

Methods

Our study is a prospective cohort study that recruited participants infected or uninfected with COVID-19 between December 2022 and March 2023. All laboratory tests and questionnaire data were completed at the First Affiliated Hospital of Nanchang University. A total of 132 participants were enrolled, with 78 COVID-19 positive patients as the positive group and 54 COVID-19 negative participants as the negative group. Semen quality was assessed by the fifth World Health Organization criteria. The general characteristics of semen samples were assessed using CASA (computer-assisted sperm analysis). DNA damage and the high density stainability was assessed by sperm chromatin structure analysis (SCSA) based on flowcytometry.

Results

The sperm concentration, progressive motility and motility in COVID-19 negative group were significantly higher than positive group. In the following DNA damage analysis, a remarkably lower sperm DNA fragmentation index (DFI) in the COVID-19 negative group. In the positive group, unhealthy lifestyles had no significant effect on semen parameters, DNA fragmentation and nuclear compaction.

Conclusions

After excluding the interference of unhealthy lifestyle, the COVID-19 infection can have a significant impact on the quality of semen, especially the DFI,. Therefore, it shows that COVID-19 can adversely affects male fertility, and this result provides advisory guidance for clinicians.

Introduction

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) is a single-stranded RNA virus belongs to the coronavirus family. Prior to the SARS-COV-2 outbreak epidemic, coronaviruses caused higher pathogenic and fatal diseases, including Middle East Respiratory Syndrome coronavirus (MERS-CoV) and Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) [1]. Several studies have shown that the virus not only affects the respiratory system but also causes pathological changes in other organs, such as the kidney [2], cardiac [3], liver, brain [4], and testes. The presence of SARS-COV-2 in saliva, respiratory fluids, blood, urine, and feces has been reported, and there is increasing evidence of SARS-COV-2 infection and inflammation in semen or testes [5, 6]. The testes and epididymis of patients who died from COVID-19 exhibited pathological changes such as interstitial edema, congestion, germ cell destruction, thinning of germinal tubules, and increased spermatogenic epithelial detachment [5, 7], which may further reveal the negative impact of COVID-19 on male fertility.

In some studies, it has been suggested that persistent fever during viral infection may disrupt the blood-testis barrier (BTB) [8], while the finding of SARS-COV-2 in the endothelial cells of the BTB offers the possibility of virus invasion [6]. In addition, Angiotensin Converting Enzyme 2 (ACE2), which has a high affinity with SARS-COV-2, is also highly expressed in the male reproductive system, especially in spermatogonia [9], which may reveal the mechanism of entry into the male reproductive organs. Studies have shown that the immune response generated in testicular tissue adversely affects sperm production, which may impair male hormonal function and fertility [10, 11].

In previous studies on the impact of COVID-19 on male reproductive system, positive results were reported. For instance, Holtmann et al. found statistically significant reductions in sperm concentration, total sperm count, total number of progressive sperm, and total number of motile sperm in 20 moderately infected COVID-19 patients [12]. Similarly, Ma et al. conducted a study on 12 COVID-19 patients and found normal sperm parameters and low DFI in eight patients, while low sperm motility and high sperm DFI were observed in four patients [13]. However, it is important to note that the sample size of these previous studies were small, despite the use of exclusion and screening criteria, they may still have lacked control of some confounders and the effect on sperm quality in infected patients needs to be confirmed in more studies with clinical samples. In our study, we aimed to analyze and compare the DFI and other parameters of sperm between the COVID-19 positive and negative groups and to exclude some confounders, after excluded the effects of disease and medicine, we investigated unhealthy lifestyle habits in the positive group.

Methods

Study design

This study was conducted by the First Affiliated Hospital of Nanchang University and approved by the Ethics Committee. As a prospective cohort study, in order to calculate the sample size required for our study, in the Gpower software, with two tails, input parameters of effect size = 0.6, alpha level = 0.05, statistical power = 0.8, the minimum required sample size was determined to be 47.Between December 2022 and March 2023, we recruited participants from the community who volunteers to participate in the study, provide semen analysis and had records of COVID-19 test. By stratified random sampling method, a total of 132 male participants were included to observe the effect of COVID-19 on male sperm. Male participants aged 30.58 ± 5.16 years old with a median age of 30 (IQR 27–34) years, and collect unhealthy lifestyle information in positive group. We have included four unhealthy lifestyle habits, smoking, drinking alcohol, staying up late and sedentariness as confounders. In the questionnaire, we defined smoking habits as smoking at least 10 cigarettes daily, alcohol consumption habits as a weekly alcohol intake over 150 g, staying up late as fall asleep after 11:00 pm [14] and sedentariness as sitting without movement for more than four hours due to work reason or habits. All participants had no history of cryptorchidism, chronic disease, infectious disease, varicocele surgery, or testicular surgery. Moreover, all patients did not take drugs affecting androgen levels and their androgen levels were within normal range. Among the 132 participants, 78 patients had COVID-19 within the last three months (COVID-19 positive group), and confirmed by two positive polymerase chain reaction tests (throat swab sampling). The other 54 participants were never infected with COVID-19 (COVID-19 negative group). Among the 78 patients, the symptoms of COVID-19 infection were between mild and moderate, and no patients were sent to the hospital for treatment. After they complete the questionnaire, semen samples were obtained through masturbation at our andrology research center and conducted further analysis. According to the fifth World Health Organization (WHO) criteria [15], three to seven days sexual abstinence duration were required.

Semen analysis

The Andrology Research Center in the First Affiliated Hospital of Nanchang University have completed the semen quality assessment. All analyses in the laboratory were performed according to the fifth WHO criteria. The semen samples received by the andrology clinic were placed in an incubator at 37℃ for 30 min to liquefaction, and the liquefied samples were treated in a laminar sterilization cabinet. The general characteristics of semen samples were assessed using computer-assisted sperm analysis (CASA), such as total sperm count (× 106 per ejaculate), Concentration(× 106 ml−1), Progressive motility (%), non-progressive motility (%), and immotility (%). The Semen assessment was performed according to the fifth WHO laboratory manual for the examination and processing of human semen. sperm motility was assessed as three types: progressive(sperm motile and active), non-progressive(sperm motile but inactive) and immotility(Sperm do not move at all).

In order to check the DNA and nuclear compaction of sperm, the DNA fragmentation index (DFI) and sperm High DNA stainability (HDS) were detected by sperm chromatin structure analysis (SCSA) based on flowcytometry. DFI and HDS ≤ 15% is considered normal, when they are more than 15%, means the DNA and nuclear compaction damaged, as abnormol.

Statistical analysis

The data analysis of this study was mainly implemented through SPSS (IBM SPSS Statistics 25). To compare differences in DFI and other parameters between the COVID-19 positive and negative groups,the parametric method was used for measurements that conformed to a normal distribution, and the independent sample test (t‐table value) method was used to compare measurements from two independent groups. The nonparametric method or Mann–Whitney U test (Z-table value) method is used for measurements that do not conform to normal distribution. After grouping the ages by median, multivariable logistic regression analysis were used by calculating the odds ratio and its 95% confidence interval to ascertain the risk factors of DFI abnormality as control of confounders. Two tailed p values ≤ 0.05 was considered statistically significant. Additionally, the results of this study were completed through the use of frequency tables and descriptive statistics.

Results

In our research included 132 participants, and the effect of lifestyles on sperm quality were analyzed in positive group. Compared to the negative group, the mean age of positive group (30.85 ± 4.58,30.81 ± 5.71; respectively) was observed not statistically significant. In the completed analysis of sexual abstinence days, semen volumes, total sperm count and sperm concentration, the sperm concentration in COVID‐19 negative group were significantly higher than positive group. Sperm motility was significantly higher in COVID-19 negative group than positive group, especially progressive motility. Furthermore, the sperm DFI was significantly higher in the positive group, sperm HDS was not remarkably lower in the COVID‐19 negative group (Table 1). In the COVID-19 positive group, the number of men with unhealthy lifestyles in the positive group were shown in Table 2 and no significant differences of semen quality parameters in the men with and without unhealthy lifestyles (Table 3). Multivariable logistic regression analyses showed that COVID-19 positive (OR = 6.760, 95% CI = 3.009–15.187) was a major risk factor for abnormal DFI (Table4).

Table 1 Comparison of semen parameters between COVID-19 positive and negative groups
Full size table
Table 2 Distribution of the four lifestyles in the COVID-19 positive group
Full size table
Table 3 Comparison of sperm parameters within each lifestyle
Full size table
Table 4 Multivariable logistic regression analysis of risk factors of DFI abnormality patients
Full size table

Discussion

Our findings show that the DFI was remarkably higher in the COVID-19 positive group (P < 0.001), which indicates a damaging effect on sperm DNA. Haghpanah et al. [16] stated that sperm DFI may serve as a promising and important factor for male infertility due to COVID-19 infection. Likewise, according to the latest WHO standards [17], sperm DFI can be used as an important complement to assess male fertility. Furthermore, in agreement with the findings of Caliskan et al. [18] observed a negative correlation between sperm DFI, sperm concentration and percentage of motility in the analysis of sperm samples from 743 infertile men. In the study by Dipankar et al. [19], all 30 COVID-19 positive participants included in the survey had a DFI more than 30%. these results further support that COVID-19 affects male infertility and plays an important role of DNA damage in sperm. In addition, we investigated the impact of unhealthy lifestyle on sperm quality in the COVID-19 positive group, but no statistically significant differences were observed. The conclusions of Donders et al. [20] are consistent with ours, they found that smoking and BMI were not associated with any sperm quality parameter in a multiple regression analysis of infected patients. In a study on the effect of lifestyle changes on semen quality. Although there were studies proved that unhealthy lifestyles impact semen quality [21], these results and our findings both indicated that sperm quality did not show significant differences in postive group, whereas the adverse effect of COVID-19 on sperm quality was further validated and a positive COVID-19 is the only risk factor of abnormal DFI.

Multiple studies have shown that SARS-COV-2 can infect the testes. Stanley et al. [22] pointed out that besides ACE2 expressed in the testis, another molecule, transmembrane serine protease 2 (TMPRSS2), is also expressed in testicular tissue and spermatozoa. It induces conformational changes by cleaving the viral S protein, thereby fusing the virus to the host cell membrane. In the study of Koch et al. [23], SARS-CoV-2 can invade target cells through the rapid pathway in TMPRSS2+ cells and the slow pathway in TMPRSS2 + cells. However, ACE2 lacked co-expression with TMPRSS2 in testicular tissues, and the association between them deserves further investigation.

In our study, sperm concentration, and motility were significantly lower in the COVID-19 positive group. It has been reported that COVID-19 induced fever may impair spermatogenesis and lead to decreased sperm quality [24], but this conclusion still faces challenges, In the prospective study of 120 individuals included by Donders et al. [20] shown no significant effect of the severity of infection and fever on sperm was observed. In addition, this analysis revealed a short-term decrease in sperm concentration (P < 0.003) and progressive motility (P < 0.02) in infected patients. According to available clinical data, most infected patients develop varying degrees orchitis and genital tract inflammation, additionally, the overproduction of cytokines that regulate the immune response (IL-6, etc.) induced by a viral infection can lead to leukocyte infiltration in the interstitium of testis, resulting in autoimmune response and formation of anti-sperm antibodies (ASA) [25] and autoimmune responses appear to play an important role in the negative effects of COVID-19 on fertility. Ertaş et al. [26] concluded that COVID-19 can significantly reduce sperm concentration and total motility. Analogous results were observed in our study, with statistically significant differences in changes with sperm concentration (P = 0.042), motility (P = 0.037), and progressive motility (P = 0.027) in infected patients compared to negatives. Studies have shown that sperm quality may revert over time in COVID-19 positive patients, but it may takes more than three months. As shown in a prospective longitudinal cohort study by Dipankar et al. [19] comparing the second sampling after 74 days with the first sampling, the number of patients with sperm concentration < 150,000/mL was reduced from fourteen to five, and 30 COVID-19 positive patients with sperm concentration (P < 0.001), viability (P = 0.014), total motility (P = 0.002) and DFI (P < 0.001) were significantly improved, but the quality remained poor. In another prospective study, Enikeev et al. [27] analyzed semen samples of 44 COVID-19 positive patients during hospitalization and three months after discharge and compared them with 44 normal controls. It was observed that positive patients returned to normal levels of all parameters three months after discharge, even in moderate or severe COVID-19 patients. These findings demonstrate that COVID-19 may cause a temporary decrease in sperm quality, gradually recovery or even rehabilitation over time, but it also needs more clinical data to confirm.

Inflammatory responses and oxidative stress (OS) have been proposed as possible mechanisms for the negative effects of COVID-19 on male fertility [28, 29]. OS and inflammation are usually correlated. SARS-CoV-2 can induce inflammatory responses and overproduction of reactive oxygen species (ROS) through immune responses and ultimately lead to OS [30]. Direct evidence is provided by the study of Hajizadeh et al. [31]. In their prospective longitudinal cohort study, the levels of inflammatory markers (IL-1β, IL-6, IL-8, IL-10, TGF-β, INF-α, and INF-γ) in the semen of the COVID-19 positive group were significantly higher than those of the control group from the first sampling to up to 60 days of follow-up thereafter (p < 0.05). In a study on the treatment of varicocele-induced decline in semen quality with medication, Melissa officinalis was found to effectively improve sperm count, motility, and chromatin structure [32], indicating the protective effect of antioxidant on the male reproductive system [33]. Similarly, in the treatment of a unilateral testicular ischemia reperfusion injury model, citral demonstrated a powerful protective effect [34], displaying strong anti-inflammatory and antioxidant effects. This also suggests that anti-inflammatory and antioxidant therapies may have a positive role in the treatment of COVID-19 patients.

The strength of our study was that we compared the semen from negative and positive participants, identified the differences and compared whether unhealthy lifestyles had an effect on positive patients. However, there are some unavoidable limitations in our study. Firstly, due to the specificity of specimens, we lack of pre-COVID-19 sperm to perform pre and post-infection comparisons. Secondly, our study was developed by clinical samples, potential selection bias and measurement error could have adversely affected the conclusions, In addition, due to the limited information on the variables, it was not yet sufficient to conduct sensitivity analysis. Thirdly, more long-term effects of the COVID-19 on male need more observations of the spermatogenic cycle. Therefore, to learn more about the effects of COVID-19 in men, need a long time patients follow to study the underlying mechanisms and find ways to mitigate the impact during and after COVID-19 infections.

Conclusion

In our study, we found that semen quality can be significantly affected during COVID-19 infection, semen concentration, progressive motility, motility, especially sperm DFI were significantly decrease, which has a greater impact on male fertility, therefore, reproductive advice can be offered to men after a COVID-19 infection to prevent adverse fertility results, for instance, it is not recommended that patients with COVID-19 infections have a pregnancy plan within three months as a spermatogenic cycle.

Availability of data and materials

The datasets used and analyzed are available from the corresponding author on reasonable request.

Abbreviations

COVID-19:

Corona virus disease 2019

CASA:

Computer-assisted sperm analysis

DFI:

DNA fragmentation index

HDS:

High DNA stainability

MERS-CoV:

Middle east respiratory syndrome coronavirus

SARS-CoV:

Severe acute respiratory syndrome coronavirus

TMPRSS2:

Transmembrane serine protease 2

ACE2:

Angiotensin converting enzyme 2

BTB:

Blood-testis barrier

BMI:

Body mass index

ASA:

Anti-sperm antibodies

OS:

Oxidative stress

ROS:

Reactive oxygen species

DNA:

Deoxyribo nucleic acid

References

  1. de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14(8):523–34.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Han X, Ye Q. Kidney involvement in COVID-19 and its treatments. J Med Virol. 2021;93(3):1387–95.

    Article  PubMed  CAS  Google Scholar 

  3. Tajbakhsh A, Gheibi Hayat SM, Taghizadeh H, Akbari A, Inabadi M, Savardashtaki A, et al. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Expert Rev Anti Infect Ther. 2021;19(3):345–57.

    Article  PubMed  CAS  Google Scholar 

  4. Hingorani KS, Bhadola S, Cervantes-Arslanian AM. COVID-19 and the brain. Trends Cardiovasc Med. 2022;32(6):323–30.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Li H, Xiao X, Zhang J, Zafar MI, Wu C, Long Y, et al. Impaired spermatogenesis in COVID-19 patients. EClinicalMedicine. 2020;28:100604.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Yao XH, Luo T, Shi Y, He ZC, Tang R, Zhang PP, et al. A cohort autopsy study defines COVID-19 systemic pathogenesis. Cell Res. 2021;31(8):836–46.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Aslan S, Eryuruk U. Necrotizing orchitis due to COVİD-19. Rev Soc Bras Med Trop. 2021;54:e04082021.

    Article  PubMed  Google Scholar 

  8. Wu H, Jiang X, Gao Y, Liu W, Wang F, Gong M, et al. Mumps virus infection disrupts blood-testis barrier through the induction of TNF-α in Sertoli cells. Faseb j. 2019;33(11):12528–40.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Wang Z, Xu X. scRNA-seq profiling of human testes reveals the presence of the ACE2 Receptor, a target for SARS-CoV-2 infection in Spermatogonia, Leydig and Sertoli Cells. Cells. 2020;9(4):96.

    Article  Google Scholar 

  10. Achua JK, Chu KY, Ibrahim E, Khodamoradi K, Delma KS, Iakymenko OA, et al. Histopathology and ultrastructural findings of fatal COVID-19 infections on testis. World J Mens Health. 2021;39(1):65–74.

    Article  PubMed  Google Scholar 

  11. Duarte-Neto AN, Teixeira TA, Caldini EG, Kanamura CT, Gomes-Gouvêa MS, Dos Santos ABG, et al. Testicular pathology in fatal COVID-19: a descriptive autopsy study. Andrology. 2022;10(1):13–23.

    Article  PubMed  CAS  Google Scholar 

  12. Holtmann N, Edimiris P, Andree M, Doehmen C, Baston-Buest D, Adams O, et al. Assessment of SARS-CoV-2 in human semen-a cohort study. Fertil Steril. 2020;114(2):233–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Ma L, Xie W, Li D, Shi L, Ye G, Mao Y, et al. Evaluation of sex-related hormones and semen characteristics in reproductive-aged male COVID-19 patients. J Med Virol. 2021;93(1):456–62.

    Article  PubMed  CAS  Google Scholar 

  14. Hvidt JEM, Knudsen UB, Zachariae R, Ingerslev HJ, Philipsen MT, Frederiksen Y. Associations of bedtime, sleep duration, and sleep quality with semen quality in males seeking fertility treatment: a preliminary study. Basic Clin Androl. 2020;30:5.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Hadi H, Ali R. WHO laboratory manual for the Examination and processing of human semen. 5th ed. Berlin: Springer; 2021.

    Google Scholar 

  16. Haghpanah A, Masjedi F, Alborzi S, Hosseinpour A, Dehghani A, Malekmakan L, et al. Potential mechanisms of SARS-CoV-2 action on male gonadal function and fertility: current status and future prospects. Andrologia. 2021;53(1):e13883.

    Article  PubMed  CAS  Google Scholar 

  17. WHO laboratory manual for the examination and processing of human semen, sixth edition. Geneva: World Health Organization: Licence: CC BY-NC-SA 3.0 IGO.; 2021.

  18. Caliskan Z, Kucukgergin C, Aktan G, Kadioglu A, Ozdemirler G. Evaluation of sperm DNA fragmentation in male infertility. Andrologia. 2022;54(11):e14587.

    Article  PubMed  CAS  Google Scholar 

  19. Dipankar SP, Kumar T, Itagi ABH, Naik BN, Kumar Y, Sharma M, et al. Semen quality in males suffering from COVID-19: a pilot study. Cureus. 2022;14(11):e31776.

    PubMed  PubMed Central  Google Scholar 

  20. Donders GGG, Bosmans E, Reumers J, Donders F, Jonckheere J, Salembier G, et al. Sperm quality and absence of SARS-CoV-2 RNA in semen after COVID-19 infection: a prospective, observational study and validation of the SpermCOVID test. Fertil Steril. 2022;117(2):287–96.

    Article  PubMed  CAS  Google Scholar 

  21. Zańko A, Siewko K, Krętowski AJ, Milewski R. Lifestyle, insulin resistance and semen quality as co-dependent factors of male infertility. Int J Environ Res Public Health. 2022;20(1):496.

    Article  Google Scholar 

  22. Stanley KE, Thomas E, Leaver M, Wells D. Coronavirus disease-19 and fertility: viral host entry protein expression in male and female reproductive tissues. Fertil Steril. 2020;114(1):33–43.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Koch J, Uckeley ZM, Doldan P, Stanifer M, Boulant S, Lozach PY. TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells. Embo j. 2021;40(16):e107821.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Bendayan M, Robin G, Hamdi S, Mieusset R, Boitrelle F. COVID-19 in men: With or without virus in semen, spermatogenesis may be impaired. Andrologia. 2021;53(1):e13878.

    Article  PubMed  CAS  Google Scholar 

  25. Mahmudpour M, Roozbeh J, Keshavarz M, Farrokhi S, Nabipour I. COVID-19 cytokine storm: the anger of inflammation. Cytokine. 2020;133:155151.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. Ertaş K, Eryilmaz R, Yokuş A, Körpe K, Gedük N, Özkan M, et al. Examining changes on testicular structure and sperm analysis of COVID-19 patients. Andrologia. 2022;54(10):e14609.

    Article  PubMed  Google Scholar 

  27. Enikeev D, Taratkin M, Morozov A, Petov V, Korolev D, Shpikina A, et al. Prospective two-arm study of the testicular function in patients with COVID-19. Andrology. 2022;10(6):1047–56.

    Article  PubMed  CAS  Google Scholar 

  28. Sengupta P, Dutta S, Roychoudhury S, D’Souza UJA, Govindasamy K, Kolesarova A. COVID-19, oxidative stress and male reproduction: possible role of antioxidants. Antioxidants (Basel). 2022;11(3):63.

    Google Scholar 

  29. Sengupta P, Dutta S. Does SARS-CoV-2 infection cause sperm DNA fragmentation? Possible link with oxidative stress. Eur J Contracept Reprod Health Care. 2020;25(5):405–6.

    Article  PubMed  CAS  Google Scholar 

  30. Delgado-Roche L, Mesta F. Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-CoV) infection. Arch Med Res. 2020;51(5):384–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  31. Hajizadeh Maleki B, Tartibian B. COVID-19 and male reproductive function: a prospective, longitudinal cohort study. Reproduction. 2021;161(3):319–31.

    Article  PubMed  Google Scholar 

  32. Rezakhaniha B, Heidari R, Abbasi M. Can Melissa officinalis improve chromatin structure and sperm parameters in a rat model of varicocele? Andrologia. 2018;50(8):e13058.

    Article  PubMed  Google Scholar 

  33. Beygi Z, Forouhari S, Mahmoudi E, Hayat SMG, Nourimand F. Role of oxidative stress and antioxidant supplementation in male fertility. Curr Mol Med. 2021;21(4):265–82.

    PubMed  CAS  Google Scholar 

  34. Rezakhaniha B, Ganjiani V, Siroosbakht S, Ahmadi N, Meimandi-Parizi A, Divar MR, et al. The evaluation of citral effects on experimental unilateral testicular ischemia/reperfusion injury. Andrologia. 2022;54(11):e14605.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank all the participants.

Funding

Natural Science Foundation of Jiangxi Province (20202BAB206014).

Author information

Author notes

  1. Shuibo Shi and Hongji Hu contributed equally to this study.

Authors and Affiliations

  1. Department of Assisted Reproduction, the First Affiliated Hospital of Nanchang University, Yongwai Street 17, Nanchang City, Jiangxi Province, China

    Shuibo Shi, Hongji Hu, Jiayao Wang, Jianhao Li & Dongshui Li

  2. Department of Clinical Laboratory, the First Affiliated Hospital of Nanchang University, Yongwai Street 17, Nanchang City, Jiangxi Province, China

    Xueming Huang

Authors
  1. Shuibo Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hongji Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jiayao Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xueming Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jianhao Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dongshui Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SBS and HJH performed the analysis and wrote the manuscript. XMH provided clinical information of the participants. JYW and JHL collected the participants information. DSL reviewed the research framework and checked the article. All authors approved the submitted version.

Corresponding author

Correspondence to Dongshui Li.

Ethics declarations

Ethics approval and consent to participate

This study was conducted by the First Affiliated Hospital of Nanchang University and approved by the Ethics Committee.

Consent for publication

Not applicable.

Competing interests

The authors have declared that no competing interests exist.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shi, S., Hu, H., Wang, J. et al. Evaluation of semen DNA integrity and related parameters with COVID-19 infection: a prospective cohort study. Virol J 20, 218 (2023). https://doi.org/10.1186/s12985-023-02192-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12985-023-02192-y

Keywords

Virology Journal

ISSN: 1743-422X